Biofil Chemicals and Pharmaceuticals Limited has received strong shareholder approval for the sale of leasehold rights of a significant portion of its industrial land in Pithampur, Madhya Pradesh. The special resolution, passed through a postal ballot, marks a strategic move for the company.

Key Highlights

• Land Details: The resolution pertains to the sale, transfer, or disposal of leasehold rights for a vacant portion of industrial land measuring 80,156 square meters.
• Location: The land is situated at Plot No. 8, Sector-3, Kheda Industrial Estate, Pithampur, District Dhar, Madhya Pradesh.
• Voting Results: An overwhelming 99.93% of votes were cast in favor of the resolution, with 8,974,224 votes supporting and only 6,503 votes against.
• Voting Process: The e-voting process was overseen by L.N. Joshi as the scrutinizer.
• Shareholder Participation: Out of 25,845 total shareholders, postal ballot notices were sent to 23,017 members via email, representing 89.06% of the total shareholder base.

Voting Details

Implications and Next Steps

The strong shareholder support for this resolution allows Biofil Chemicals and Pharmaceuticals Limited to proceed with the disposal of leasehold rights for the vacant industrial land. This move could potentially unlock value from non-core assets and provide the company with additional financial flexibility.

The company's management will now be able to execute the sale or transfer of the leasehold rights as per the terms approved by the shareholders. This decision may have significant implications for Biofil Chemicals' asset portfolio and future strategic plans.

Investors and stakeholders will likely be watching closely to see how the company utilizes the proceeds from this potential sale and its impact on Biofil Chemicals' overall financial position and operational strategy.

The successful passage of this resolution demonstrates strong alignment between the company's management and its shareholders on this strategic decision. It also reflects the company's commitment to transparent corporate governance practices, as evidenced by the detailed voting process and results disclosure.

Biofil Chemicals & Pharmaceuticals Limited has announced the appointment of Mr. Smitesh Shah as an Additional Director in the category of Promoter Non-Executive Non-Independent Director, effective August 23, 2025. This strategic move comes as part of the company's efforts to strengthen its leadership team.

Appointment Details

The appointment of Mr. Shah, which is subject to shareholder approval at the upcoming 40th Annual General Meeting (AGM), was made upon the recommendations of the Nomination and Remuneration Committee. According to the company's disclosure, Mr. Shah will hold office until the ensuing AGM or within three months from the appointment date, whichever is earlier.

About Smitesh Shah

Mr. Smitesh Shah, aged 65, brings a wealth of experience to Biofil Chemicals & Pharmaceuticals Limited:

• Educational Background: Holds a B.Sc. degree
• Industry Experience: 45 years in the pharmaceuticals industry
• Current Directorships: Holds directorships in 6 other companies
• Family Ties: Uncle of Ketan Shah, the company's Chairman and Managing Director

Corporate Governance

The company has confirmed that Mr. Shah is not debarred from holding office by virtue of any SEBI Order or any other authority. This confirmation aligns with SEBI's requirements for listed companies to ensure the integrity of their board members.

Board Meeting Details

The Board of Directors meeting where this appointment was approved commenced at 5:00 PM and concluded at 5:45 PM on August 23, 2025.

Company Information

Biofil Chemicals & Pharmaceuticals Limited's registered office is located at 11/12, Sector E Sanwer Road, Indore-452015, Madhya Pradesh.

This appointment reflects Biofil Chemicals & Pharmaceuticals Limited's commitment to enhancing its leadership structure with experienced industry professionals. Shareholders will have the opportunity to ratify this appointment at the forthcoming Annual General Meeting.